Oksana Yaskiv
Research Subjects
Oksana Yaskiv has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Constantin Friedman
Northwell Health Laboratories
2 shared publications - Dimitris Samaras
Stony Brook University
2 shared publications - Gregory J. Zelinsky
Stony Brook University
2 shared publications - Natallia Sheuka
Northwell Health Laboratories
2 shared publications - Paul Friedman
Northwell Health Laboratories
2 shared publications - Souradeep Chakraborty
Stony Brook University
2 shared publications
Latest Publications
- 25 September 2026
- Published by Springer Nature
- p. 364-374
Pathologist Attention–Aligned Report Generation for Prostate Histopathology
- 25 September 2026
- Published by Springer Nature
- p. 364-374
Pathologist Attention–Aligned Report Generation for Prostate Histopathology
- 8 July 2026
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 50 (10) , 1139-1151
Histiocyte-Rich Renal Epithelial Neoplasm
So-called hybrid oncocytic tumor (HOT) is the renal neoplasm most commonly associated with the germline folliculin ( FLCN ) mutations that define Birt-Hogg-Dubé syndrome. However, the spectrum of renal epithelial neoplasms associated with FLCN gene mutations has recently expanded to include neoplasms with somatic FLCN mutations and those with variant morphology. Some of these FLCN -mutated neoplasms overlap morphologically and immunohistochemically with TSC/MTOR -mutated and TFE3/TFEB fusion renal cell carcinomas, which makes sense given their overlapping genetic pathways. One morphology that has been reported in 1 to 2 cases each across multiple studies is that of a “histiocyte-rich” renal epithelial neoplasm, characterized by acinar spaces lined by neoplastic oncocytic epithelial cells variably distended by luminal histiocytes. An unanswered question is how frequently this morphology is associated with FLCN mutations. We identified 11 previously unreported cases of histiocyte-rich renal epithelial neoplasms and performed immunohistochemistry and next-generation sequencing. Five out of 11 cases (45%) demonstrated FLCN mutations, including at least 3 cases with evidence supporting occult Birt-Hogg-Dubé syndrome. All FLCN- mutated neoplasms were diffusely immunoreactive for glycoprotein nonmetastatic B (GPNMB), but so were 3 of the 6 morphologically similar cases in which FLCN mutations were not detected. The 2 syndromic cases with adequate surrounding kidney for evaluation demonstrated GPNMB-positive cysts lined by cells with similar cytology to that of the neoplasms, possibly representing precursor lesions. In summary, histiocyte-rich renal epithelial neoplasm is a morphologic pattern that is strongly but not invariably associated with FLCN mutations. Recognition of this pattern is helpful in that it may provide the first clue to the presence of occult Birt-Hogg-Dubé syndrome.
- 8 July 2026
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 50 (10) , 1139-1151
Histiocyte-Rich Renal Epithelial Neoplasm
So-called hybrid oncocytic tumor (HOT) is the renal neoplasm most commonly associated with the germline folliculin ( FLCN ) mutations that define Birt-Hogg-Dubé syndrome. However, the spectrum of renal epithelial neoplasms associated with FLCN gene mutations has recently expanded to include neoplasms with somatic FLCN mutations and those with variant morphology. Some of these FLCN -mutated neoplasms overlap morphologically and immunohistochemically with TSC/MTOR -mutated and TFE3/TFEB fusion renal cell carcinomas, which makes sense given their overlapping genetic pathways. One morphology that has been reported in 1 to 2 cases each across multiple studies is that of a “histiocyte-rich” renal epithelial neoplasm, characterized by acinar spaces lined by neoplastic oncocytic epithelial cells variably distended by luminal histiocytes. An unanswered question is how frequently this morphology is associated with FLCN mutations. We identified 11 previously unreported cases of histiocyte-rich renal epithelial neoplasms and performed immunohistochemistry and next-generation sequencing. Five out of 11 cases (45%) demonstrated FLCN mutations, including at least 3 cases with evidence supporting occult Birt-Hogg-Dubé syndrome. All FLCN- mutated neoplasms were diffusely immunoreactive for glycoprotein nonmetastatic B (GPNMB), but so were 3 of the 6 morphologically similar cases in which FLCN mutations were not detected. The 2 syndromic cases with adequate surrounding kidney for evaluation demonstrated GPNMB-positive cysts lined by cells with similar cytology to that of the neoplasms, possibly representing precursor lesions. In summary, histiocyte-rich renal epithelial neoplasm is a morphologic pattern that is strongly but not invariably associated with FLCN mutations. Recognition of this pattern is helpful in that it may provide the first clue to the presence of occult Birt-Hogg-Dubé syndrome.
- Open Access
Decoding the visual attention of pathologists to reveal their level of expertise
We present a method for classifying the expertise of a pathologist based on how they allocated their attention during a cancer reading. We engage this decoding task by developing a novel method for predicting the attention of pathologists as they read whole-slide Images (WSIs) of prostate and make cancer grade classifications. Our ground truth measure of a pathologists' attention is the x, y and z (magnification) movement of their viewport as they navigated through WSIs during readings, and to date we have the attention behavior of 43 pathologists reading 123 WSIs. These data revealed that specialists have higher agreement in both their attention and cancer grades compared to general pathologists and residents, suggesting that sufficient information may exist in their attention behavior to classify their expertise level. To attempt this, we trained a transformer-based model to predict the visual attention heatmaps of resident, general, and specialist (GU) pathologists during Gleason grading. Based solely on a pathologist's attention during a reading, our model was able to predict their level of expertise with 75.3%, 56.1%, and 77.2% accuracy, respectively, better than chance and baseline models. Our model therefore enables a pathologist's expertise level to be easily and objectively evaluated, important for pathology training and competency assessment. Tools developed from our model could also be used to help pathology trainees learn how to read WSIs like an expert.
Open AccessDecoding the visual attention of pathologists to reveal their level of expertise
We present a method for classifying the expertise of a pathologist based on how they allocated their attention during a cancer reading. We engage this decoding task by developing a novel method for predicting the attention of pathologists as they read whole-slide Images (WSIs) of prostate and make cancer grade classifications. Our ground truth measure of a pathologists' attention is the x, y and z (magnification) movement of their viewport as they navigated through WSIs during readings, and to date we have the attention behavior of 43 pathologists reading 123 WSIs. These data revealed that specialists have higher agreement in both their attention and cancer grades compared to general pathologists and residents, suggesting that sufficient information may exist in their attention behavior to classify their expertise level. To attempt this, we trained a transformer-based model to predict the visual attention heatmaps of resident, general, and specialist (GU) pathologists during Gleason grading. Based solely on a pathologist's attention during a reading, our model was able to predict their level of expertise with 75.3%, 56.1%, and 77.2% accuracy, respectively, better than chance and baseline models. Our model therefore enables a pathologist's expertise level to be easily and objectively evaluated, important for pathology training and competency assessment. Tools developed from our model could also be used to help pathology trainees learn how to read WSIs like an expert.
- Open Access
Immune Cell Profiles and Cytokine Levels of Patients with Interstitial Cystitis/Bladder Pain Syndrome
Aims: To quantify the number of immune cells in the bladder urothelium and concentrations of urinary cytokines in patients with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). To identify differences in these measures in IC/BPS patients with Hunner’s lesions (IC/BPS-HL) and without Hunner’s lesions (IC/BPS-NHL). Methods: Bladder tissue biopsies were obtained from 48 patients with IC/BPS-HL and unaffected controls (UC) and stained with antibodies for various immune cell markers such as CD138, CD20 and CD56. Levels of cytokines (Interferon (IFN)-γ, Interleukin (IL)-1β, IL-2, IL- 4, IL-6, IL-8, IL12P70, IL-13, and TNF-α) were measured from normalized urine obtained from 18 IC/BPS-HL, 18 IC/BPS-NHL, and 4 UC. Results: Numbers of CD138+ plasma cells, CD20+ B cells, and CD3+ T cells were significantly increased (50 fold, 30 fold, and an almost 3 fold increase, respectively; p-values: 1.34E-06, 3.26E-04, and 2.52E-6) in the bladders of IC/BPS-HL patients compared to UC. Patients with IC/BPS-HL had significantly elevated urinary levels of IL-6 (p=0.0028) and TNF-α (p=0.009) compared to patients with IC/BPS-NHL and UC. In contrast, IL-12p70 levels were significantly higher in the patients with IC/BPS-NHL than in HL patients (p=0.033). No significant difference in IL-12p70 levels were observed between IC/BPS-HL and UC. Conclusion: Different cytokines were elevated in the urine of IC/BPS patients with and without HL, suggesting differences in underlying disease processes. Elevated levels of CD138+, CD20+, and CD3+ cells in HL indicate B and T-cell involvement in lesion formation. Determining which cytokines and immunological pathways are present in IC/BPS-HL could elucidate the disease mechanism.
Open AccessImmune Cell Profiles and Cytokine Levels of Patients with Interstitial Cystitis/Bladder Pain Syndrome
Aims: To quantify the number of immune cells in the bladder urothelium and concentrations of urinary cytokines in patients with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). To identify differences in these measures in IC/BPS patients with Hunner’s lesions (IC/BPS-HL) and without Hunner’s lesions (IC/BPS-NHL). Methods: Bladder tissue biopsies were obtained from 48 patients with IC/BPS-HL and unaffected controls (UC) and stained with antibodies for various immune cell markers such as CD138, CD20 and CD56. Levels of cytokines (Interferon (IFN)-γ, Interleukin (IL)-1β, IL-2, IL- 4, IL-6, IL-8, IL12P70, IL-13, and TNF-α) were measured from normalized urine obtained from 18 IC/BPS-HL, 18 IC/BPS-NHL, and 4 UC. Results: Numbers of CD138+ plasma cells, CD20+ B cells, and CD3+ T cells were significantly increased (50 fold, 30 fold, and an almost 3 fold increase, respectively; p-values: 1.34E-06, 3.26E-04, and 2.52E-6) in the bladders of IC/BPS-HL patients compared to UC. Patients with IC/BPS-HL had significantly elevated urinary levels of IL-6 (p=0.0028) and TNF-α (p=0.009) compared to patients with IC/BPS-NHL and UC. In contrast, IL-12p70 levels were significantly higher in the patients with IC/BPS-NHL than in HL patients (p=0.033). No significant difference in IL-12p70 levels were observed between IC/BPS-HL and UC. Conclusion: Different cytokines were elevated in the urine of IC/BPS patients with and without HL, suggesting differences in underlying disease processes. Elevated levels of CD138+, CD20+, and CD3+ cells in HL indicate B and T-cell involvement in lesion formation. Determining which cytokines and immunological pathways are present in IC/BPS-HL could elucidate the disease mechanism.